Evaluation of a rural pediatric obesity program highlights strengths in structured care delivery while identifying gaps in ...
IP Group PLC (IPZYF) reports a 13% increase in NAV per share, driven by strategic investments and robust third-party capital support, despite facing market and regulatory uncertainties.
Eli Lilly (NYSE: LLY) has climbed in recent years as growth investors piled into the stock. Generally, big pharmaceutical ...
A new study indicated that excess fat stored around the waist or visceral fat was more strongly associated with heart failure ...
Following the patent expiry of Novo Nordisk’s semaglutide on March 20, 2026, Indian drugmakers including Natco, Dr. Reddy’s, ...
Zacks Investment Research on MSN
LLY's next-gen obesity drug meets goal in first phase III study for T2D
Eli Lilly LLY announced positive top-line results from a late-stage study evaluating its experimental once-weekly weight-loss ...
Currently on a Mounjaro injectable, he wants to get rid of it some day and doesn’t want it to define his life. “It got me off ...
FDA approves higher 7.2mg Wegovy dose for Novo Nordisk (NVO), showing 20.7% weight loss. April launch aims to challenge Eli ...
Waist circumference, not BMI, was tied to increased risk for adiposity-related heart failure, and the association was ...
It's 'definitely not a measure of fatness,' and it doesn't accurately define what it means to be overweight. Body mass index ...
Childhood obesity may be quietly undermining one of the central promises of American life. A study by a Rutgers researcher ...
Childhood obesity may be quietly undermining one of the central promises of American life. A study by a Rutgers researcher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results